Junkai J. Lee
Affiliations: | Biostatistics | The University of Texas School of Public Health |
Area:
Biostatistics BiologyGoogle:
"Junkai Lee"Children
Sign in to add traineeXuemin Gu | grad student | 2012 | The University of Texas School of Public Health |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ruder D, Papadimitrakopoulou V, Shien K, et al. (2018) Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of -altered non-small cell lung cancer. Oncotarget. 9: 33995-34008 |
Gu X, Chen N, Wei C, et al. (2016) Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy Development. Statistics in Biosciences. 8: 99-128 |
Papadimitrakopoulou V, Lee JJ, Wistuba II, et al. (2016) The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology |
Liu S, Lee JJ. (2015) An overview of the design and conduct of the BATTLE trials. Chinese Clinical Oncology. 4: 33 |
Gu X, Yin G, Lee JJ. (2013) Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints. Contemporary Clinical Trials. 36: 642-50 |
Tam AL, Kim ES, Lee JJ, et al. (2013) Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 436-42 |
Tsao AS, Liu S, Lee JJ, et al. (2012) Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1645-52 |
Kim ES, Herbst RS, Wistuba II, et al. (2011) The BATTLE trial: personalizing therapy for lung cancer. Cancer Discovery. 1: 44-53 |
Kadara H, Behrens C, Yuan P, et al. (2011) A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1490-501 |
Gu X, Lee JJ. (2010) A simulation study for comparing testing statistics in response-adaptive randomization. Bmc Medical Research Methodology. 10: 48 |